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Hepatitis B is a major public health problem. Approxi-
mately one-third of the world’s population has serological
evidence of infection with hepatitis B virus (HBV). 350
million of these are carriers who have chronic HBV infec-
tion, and about a million of these carriers die each year
from chronic liver disease, including cirrhosis and liver
cancer. Fortunately, HBV is a vaccine preventable disease,
and the increasing adoption of this vaccine has led to dra-
matic reductions in the morbidity and mortality caused by
this virus. However, as much as 10% of the population
fails to mount a protective immune response after vaccina-
tion. Twin and other epidemiological studies have demon-
strated an unusually high heritability to this trait, which
suggests a high likelihood of identifying genetic variation
influencing HBV vaccine response. In search of such varia-
tion, we performed a two stage Genome Wide Association
Scan (GWAS) in participants of a vaccine efficacy trial
from Batam, Indonesia. In Stage 1, we used the fixed con-
tent Illumina Infinium 550K SNP BeadChip to genotype
2000 vaccinees. Tests of association were performed to
identify 7,000 SNPs to carry forward to a second stage of
2,300 vaccinees. Several independent regions attained gen-
ome-wide significance, including the HLA-DR and HLA-
DP regions. Additional details on the study design and
results will be discussed in the presentation.
Author details
1Genome Institute of Singapore, Singapore 138672.
2Department of Medical
Microbiology and Virology, University Medical Center Utrecht, 3584 CX,
Utrecht, The Netherlands.
3Eijkman Institute for Molecular Biology, Jakarta
10430, Indonesia.
4Current Address: Institute for Human Genetics, University
of California, San Francisco, CA 94143; and Blood Systems Research Institute,
270 Masonic Avenue, San Francisco, CA 94118, USA.
Published: 10 January 2011
doi:10.1186/1753-6561-5-S1-O3
Cite this article as: Png et al.: Genetic determinants of hepatitis B
vaccine response. BMC Proceedings 2011 5(Suppl 1):O3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: pnge@gis.a-star.edu.sg
1Genome Institute of Singapore, Singapore 138672
Full list of author information is available at the end of the article
Png et al. BMC Proceedings 2011, 5(Suppl 1):O3
http://www.biomedcentral.com/1753-6561/5/S1/O3
© 2011 Png et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.